Nociceptive inhibition of migrating myoelectric complex by nitric oxide and monoaminergic pathways in the rat

The American Journal of Physiology
P M HellströmE Theodorsson

Abstract

This study investigated the role of nitric oxide (NO) and adrenergic and dopaminergic mechanisms in reflex inhibition of the migrating myoelectric complex (MMC) after intraperitoneal administration of acid in rats. Acid instilled immediately after an activity front inhibited the migrating complex and prolonged the cycle length from 13.0 +/- 0.7 to 98.5 +/- 17.2 min (P < 0.001). Administration of N omega-nitro-L-arginine, reserpine, or guanetidine before acid decreased the prolonged cycle length to 18.1 +/- 2.8 (P < 0.001), 19.0 +/- 2.0 (P < 0.001), and 27.5 +/- 9.3 min (P < 0.001), respectively. Similarly, haloperidol given before acid shortened the prolonged cycle length to 46.7 +/- 5.2 min (P < 0.05). There was no effect of phentolamine in combination with propranolol or hexamethonium given alone. After intraperitoneal instillation of acid there was an increase in the plasma levels of somatostatin and a decrease of calcitonin gene-related peptide, but there was no change of neuropeptide Y, vasoactive intestinal peptide, substance P, neurokinin A, or neurotensin. The results indicate that NO and adrenergic, dopaminergic, and somatostatinergic mechanisms cooperate in inhibiting the MMC after nociceptive stimulation of the perit...Continue Reading

References

Jan 1, 1979·Scandinavian Journal of Gastroenterology·H AbrahamssonK Glise
Jun 1, 1979·European Journal of Pharmacology·J B Furness, M Costa
Aug 1, 1978·The American Journal of Digestive Diseases·L BuenoY Ruckebusch
Feb 1, 1977·Archives of Surgery·J SmithR M Weinshilboum
Dec 1, 1992·Gastroenterology·M E Stark, J H Szurszewski
Dec 15, 1992·European Journal of Pharmacology·A CalignanoS Moncada
Aug 30, 1985·Biochemical and Biophysical Research Communications·E Theodorsson-NorheimP G Lindgren
Oct 1, 1987·Scandinavian Journal of Gastroenterology·L EnochssonC Johansson
Jun 1, 1985·Scandinavian Journal of Clinical and Laboratory Investigation·E Theodorsson-NorheimJ M Lundberg
Dec 1, 1973·Annals of Surgery·A DuboisI J Kopin
Aug 1, 1984·The Journal of Clinical Endocrinology and Metabolism·V GrillS Efendić
Jul 1, 1983·Regulatory Peptides·E Theodorsson-Norheim, S Rosell
Jun 1, 1982·Canadian Journal of Physiology and Pharmacology·T Y El-SharkawyN E Diamant
Jan 1, 1980·Scandinavian Journal of Gastroenterology·H Glise, H Abrahamsson
Dec 1, 1996·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P M Hellström, T Ljung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here